MICHAEL W ROGERS Insider Trading $ARPO Aerpio Pharmaceuticals, Inc.
Get free email notifications about insider trading for MICHAEL W ROGERS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W ROGERS. MICHAEL W ROGERS is Executive Vice President in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Chief Financial Officer in ACORDA THERAPEUTICS INC ($ACOR) and in EyePoint Pharmaceuticals, Inc. ($EYPT) and Director in pSivida Corp. ($PSDV) and Chief Financial Officer in Aerpio Pharmaceuticals, Inc. ($ZETAII) and Director in Aravive, Inc. ($ARAV) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).
MICHAEL W ROGERS in Aerpio Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W ROGERS: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Feb 20 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL W ROGERS in Aerpio Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACOR, ARPO, AKBA, ARAV, IDEV, EYPT, KERX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 3.27 | 215,328 | 704,123 | 215,328 | |
| Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 3.27 | 215,328 | 704,123 | 215,328 | |
| Apr 25 2018 | ARPO | Aerpio Pharmaceuti ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 3.59 | 144,000 | 516,960 | 144,000 | |
| Dec 18 2017 | ZETAII | Aerpio Pharmaceuti ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 5.50 | 293,006 | 1,611,533 | 0 |
Page: 1